Pfizer Cytarabine Injectable (10137_61703031922)
Important Purchase Information: Please ensure you select the correct Choose Product Details and Unit of Measure (UoM) before adding this item to your cart.
Note: Product images may vary slightly by variant.
Pfizer Cytarabine Injectable (10137_61703031922)
Important Purchase Information: Please ensure you select the correct Product Option and Unit of Measure (UoM) before adding this item to your cart.
Note: Product images may vary slightly by variant.
Description
Pfizer's Cytarabine Injectable is designed to meet the essential needs of chemotherapy treatments. Available in various strengths, such as 100 mg/ml and 20 mg/ml, this product comes in different vial sizes including 5 ml, 20 ml, 25 ml, and 50 ml. The Onco-Tainâ„¢ Glass Fliptop Vial ensures maximum sterility and ease of access, making it convenient for single-dose, multiple-dose, and pharmacy bulk packaging needs.
This aqueous Cytarabine solution is effective for treating multiple forms of leukemia, as well as certain non-Hodgkin lymphomas. It targets rapidly dividing cancer cells by interfering with DNA synthesis, making it a critical component of chemotherapy protocols. The versatility in vial volumes and strengths allows healthcare professionals to customize dosages to patient-specific requirements, optimizing treatment efficacy while minimizing waste.
Key Features:
- Comes in various dosages and vial sizes, allowing precise tailoring to patient needs and treatment protocols. This flexibility supports both single and multiple-dose administrations.
- The Onco-Tainâ„¢ Glass Fliptop Vial design ensures ease of use and maintains sterility, providing confidence and safety in pharmaceutical handling.
Uses:
- Cytarabine is primarily used in the treatment of various types of leukemia, such as acute myeloid leukemia and acute lymphocytic leukemia. It is also effective in treating non-Hodgkin lymphoma and certain other hematologic disorders.
- As an antimetabolite, Cytarabine interferes with DNA synthesis, thereby inhibiting the proliferation of malignant cells. It is often used in chemotherapy regimens due to its effectiveness in targeting rapidly dividing cancer cells.
FAQs:
1. What is Cytarabine used for?
Cytarabine is used in the treatment of leukemias, particularly acute myeloid leukemia and acute lymphocytic leukemia, and is also used for certain other hematologic disorders.
2. How is Cytarabine administered?
Cytarabine is administered via injection, which can be delivered intravenously or subcutaneously, depending on the condition being treated.
3. What are common side effects of Cytarabine?
Common side effects include nausea, vomiting, diarrhea, and hair loss. It's important to discuss potential side effects with a healthcare provider.
Specifications
Accepted Licenses
For Business Accounts:
- Pharmacy or wholesale distributor license issued by the state board
- License address must exactly match the shipping address
- License must be from the same state as the shipping address
For Individual Practitioners:
- Doctor, dentist, or nurse practitioner license issued by the state board
- Address does not need to match, but license must still be from the same state as the shipping destination
Note: A DEA license will not meet the requirement.
Please email the appropriate license to support@bttnusa.com so that we can confirm your eligibility to purchase pharmaceutical products.